Divergent effects of liraglutide, exendin-4, and sitagliptin on beta-cell mass and indicators of pancreatitis in a mouse model of hyperglycaemia.
<h4>Aims</h4>Glucagon-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 (DPP4) inhibitors improve glucose tolerance by still incompletely understood mechanisms. Each class of antihyperglycemic drugs has also been proposed to increase pancreatitis risk. Here, we compare...
Saved in:
| Main Authors: | Angeles Mondragon, Daniel Davidsson, Styliana Kyriakoudi, Annika Bertling, Rosa Gomes-Faria, Patrizia Cohen, Stephen Rothery, Pauline Chabosseau, Guy A Rutter, Gabriela da Silva Xavier |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0104873 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perioperative hyperglycaemia
by: B.M. Gardner
Published: (2012-06-01) -
The patient with hyperglycaemia
by: B.M. Gardner
Published: (2013-06-01) -
JNK3 Is Required for the Cytoprotective Effect of Exendin 4
by: Hélène Ezanno, et al.
Published: (2014-01-01) -
Hyperglycaemia in criticaly ill patients
by: Tatiana Valer'evna Klypa, et al.
Published: (2015-03-01) -
Liraglutide for the treatment of obesity
by: Elmien Bronkhorst, et al.
Published: (2016-05-01)